Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
Condition:   Pulmonary Embolism Interventions:   Drug: Alteplase 20 Mg Powder for Solution for Injection Vial;   Device: Ultrasound assisted Thrombolysis Sponsors:   Rigshospitalet, Denmark;   Herlev and Gentofte Hospital;   University Hospital Bispebjerg and Frederiksberg;   Hillerod Hospital, Denmark;   Copenhagen University Hospital, Hvidovre Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2019 Category: Research Source Type: clinical trials

Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance
Condition:   Stroke, Acute, Stroke Ischemic Interventions:   Drug: Tenecteplase;   Drug: Intravenous tissue plasminogen activator (tPA) Sponsors:   Melbourne Health;   Austin Health, Eastern Health, Monash Health, Western Health, Alfred Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2019 Category: Research Source Type: clinical trials

Intravenous Thrombolysis Registry for Acute Ischemic Stroke in China
Condition:   Ischemic Stroke Interventions:   Drug: Alteplase;   Drug: Urokinase Sponsor:   General Hospital of Shenyang Military Region Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2019 Category: Research Source Type: clinical trials

Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
Conditions:   Pulmonary Embolism With Acute Cor Pulmonale;   Pulmonary Embolism;   Pulmonary Embolism With Pulmonary Infarction;   Pulmonary Embolism Subacute Massive;   Right Ventricular Dysfunction;   Right Ventricular Failure Interventions:   Drug: Alteplase;   Drug: Unfractionated heparin;   Drug: Placebo;   Drug: Apixaban Sponsors:   Victor Tapson, MD;   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2019 Category: Research Source Type: clinical trials

Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke
Conditions:   Stroke, Acute;   Thromboses, Intracranial Interventions:   Drug: Tenecteplase;   Drug: Alteplase Sponsor:   University of Calgary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials